Does anyone know anything about a trial in the design stage of pembrolizumab (Keytruda) + insight PD-1 antibody?
I have the CDK12 mutation, which we’re currently treating with taxotere + carbolplatin in clinical trial. I just had my 5th infusion. After 4 infusions, my PSA has dropped from 948 to 540. The goal is to keep me stable until the start of the pembro+ trial. I’d like to find more about the upcoming trial, including academic papers, but I’m not finding anything.
Thanks.
— John